Telix Pharmaceuticals Limited Stock
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.33 AUD | -2.23% |
|
+7.05% | +36.88% |
| 06-23 | ASX Biggest Gainers | MT |
| 06-02 | Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration; Shares Down 3% | MT |
| Market Cap | 5.2B 3.59B 3.15B 2.9B 2.72B 5.1B 339B 34.9B 13.5B 167B 13.49B 13.19B 581B | P/E 2026 * |
1,029x | P/E 2027 * | 109x |
|---|---|---|---|---|---|
| Enterprise Value | 5.61B 3.87B 3.4B 3.13B 2.93B 5.5B 365B 37.63B 14.56B 181B 14.55B 14.23B 626B | EV / Sales 2026 * |
4.12x | EV / Sales 2027 * | 3.55x |
| Free-Float |
83.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | -2.23% | ||
| 1 week | +7.05% | ||
| Current month | +17.65% | ||
| 1 month | +14.15% | ||
| 3 months | +20.42% | ||
| 6 months | +28.93% | ||
| Current year | +36.88% |
| 1 week | 14.07 |  | 16.06 |
| 1 month | 12.17 | | 16.06 |
| Current year | 8.26 | | 16.06 |
| 1 year | 8.26 | | 25.87 |
| 3 years | 8.2 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2017-01-02 | |
Darren Smith
DFI | Director of Finance/CFO | 60 | 2022-07-30 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 2017-01-02 | |
Mark Nelson
CHM | Chairman | 66 | 2026-02-02 |
Jann Skinner
BRD | Director/Board Member | 68 | 2018-06-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Buy | Director | 10,200 | 0.0030% | ||
| 05-25 | Free | Director | 21,597 | 0.0064% | ||
| 05-25 | Free | Founder | 27,121 | 0.0080% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.23% | +7.05% | -36.94% | +30.14% | 3.68B | |
| -0.48% | +7.20% | -5.08% | +2.45% | 46.36B | |
| -0.04% | +7.65% | +376.25% | +617.73% | 37.88B | |
| +1.99% | +13.03% | +19.93% | -11.29% | 31.12B | |
| +0.72% | +2.21% | +9.16% | +54.25% | 30.61B | |
| -4.16% | -4.44% | +8.53% | +16.06% | 24.69B | |
| -1.38% | +13.54% | - | - | 16.25B | |
| +0.87% | +14.97% | +70.76% | +132.72% | 14.85B | |
| +1.00% | +10.30% | +13.31% | +22.84% | 13.58B | |
| +2.81% | +6.32% | +102.84% | +106.37% | 12.95B | |
| Average | -0.12% | +8.02% | +62.08% | +107.92% | 23.2B | |
| Weighted average by Cap. | -0.08% | +7.69% | +81.38% | +134.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.36B 939M 824M 759M 711M 1.33B 88.61B 9.12B 3.53B 43.79B 3.53B 3.45B 152B | 1.59B 1.1B 965M 889M 833M 1.56B 104B 10.69B 4.14B 51.3B 4.13B 4.04B 178B |
| Net income | 5.83M 4.03M 3.53M 3.25M 3.05M 5.71M 380M 39.12M 15.14M 188M 15.12M 14.79M 651M | 43.23M 29.85M 26.17M 24.13M 22.59M 42.36M 2.82B 290M 112M 1.39B 112M 110M 4.83B |
| Net Debt | 408M 282M 247M 228M 213M 400M 26.59B 2.74B 1.06B 13.14B 1.06B 1.04B 45.57B | 447M 309M 271M 250M 234M 438M 29.14B 3B 1.16B 14.4B 1.16B 1.13B 49.94B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | A$15.33 | -2.23% | 1,329,596 |
| 26-06-25 | A$15.68 | -0.32% | 1,745,963 |
| 26-06-24 | A$15.73 | +8.04% | 3,701,343 |
| 26-06-23 | A$14.56 | +2.46% | 1,878,642 |
| 26-06-22 | A$14.21 | -2.00% | 1,273,119 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
